Skip to main content

Table 1 Baseline characteristics of patients

From: Combined quality and dose-volume histograms for assessing the predictive value of 99mTc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer

Characteristics Value, n (%) or median (range)
Sex
 Male 12 (46%)
 Female 14 (54%)
Age (years) 73 (45-83)
Prior liver surgery 6 (23%)
Prior bevacizumab 15 (58%)
Lesion volume (ml) 5.8 (1.8–17.57)
Tumoural liver volume (ml) 73 (7.8–201.5)
Non-tumoural liver volume (ml) 1354 (913–4267)
Type of targeting  
 Whole liver, common hepatic artery 8 (30%)
 Whole liver, left and right hepatic arteries 6 (23%)
 Uni-lobar 12 (47%)
Delay between predictive and post-treatment dosimetry (days) 9 (6–33)
Net administered activity (MBq) 1262 (675–3314)